
InMode delivers $92.1 million Q3 revenue, maintains 2026 outlook
Pontos principais
- InMode (NASDAQ:INMD) reported third-quarter 2026 revenue of US$92.1 million, compared with US$93.2 million a year earlier.
- GAAP net income declined to US$18.9 million from US$21.9 million, while operating margin narrowed to 19% from 22%.
- InMode maintained its 2026 revenue forecast of US$365 million–US$375 million, with non-GAAP diluted earnings expected between US$1.29 and US$1.34 per share.
InMode (NASDAQ:INMD) reported third-quarter 2026 revenue of US$92.1 million, compared with US$93.2 million in the same period last year, while reaffirming its full-year financial outlook.
Quarterly revenue declined approximately 1.2% year-over-year, while GAAP net income fell to US$18.863 million from US$21.863 million and diluted earnings per share decreased to US$0.32 from US$0.34.
Consumables and service revenue declined 3% to US$19.3 million, while international capital equipment revenue increased and US capital equipment revenue decreased.
GAAP operating margin narrowed to 19% from 22%, although gross margin remained at 78%.
InMode expects full-year 2026 revenue of US$365 million–US$375 million, non-GAAP gross margin of 74%–76%, non-GAAP operating income of US$68 million–US$73 million and non-GAAP diluted earnings per share of US$1.29–US$1.34.
InMode develops minimally invasive aesthetic and medical treatment technologies, including energy-based devices used in skin treatments, body contouring and other medical aesthetic procedures.
The company held US$512.7 million in cash, marketable securities and short-term deposits at September 30, 2026, while its Special Committee completed its work and investor relations activities were set to resume.


